REV Clinical

REV Clinical is a multinational clinical contract research organization headquartered in Bakersfield, California, with additional operations in Ahmedabad, India, that specializes in designing and managing clinical trials across core therapeutic areas including oncology, neurology, ophthalmology, and rare diseases. Formerly known as CBCC Global Rese... arch, the company announced a comprehensive rebrand and name change to REV Clinical in January 2026, reflecting its focus on designing and delivering the industry's most advanced clinical trials with leading sponsors globally. The name REV reflects Reliability, Excellence, and Velocity, capturing the organization's commitment to designing and executing studies with both speed and integrity. Led by Chief Executive Officer Manoj Vyas, REV Clinical carries forward its deep heritage and expertise in clinical oncology and rare diseases from its founding out of the Comprehensive Blood & Cancer Center in Bakersfield, California, and positions itself for its next stages of growth with leading pharmaceutical companies based on advanced clinical trial design, a global site network, executional excellence, and resulting speed in generating clinical trial results. REV Clinical provides end-to-end clinical trial services spanning clinical study design, project management, data analysis, regulatory strategy, and medical writing across Phase I through Phase IV clinical trials. With a growing international footprint, REV delivers speed, flexibility, and capital-efficient execution from first-in-human through late-phase studies, with teams that operate as an extension of client organizations. The company maintains a focus on the most advanced clinical designs, patient access in its global site networks, and very close engagement with sponsors, continuing to deliver the close engagement, communication, and trust that partners have come to expect while advancing clinical research capabilities for pharmaceutical and biotechnology companies worldwide.Read More